446
Views
2
CrossRef citations to date
0
Altmetric
REVIEW

A Scoping Review of Trials Designed to Achieve Remission of Type 2 Diabetes with Lifestyle Intervention Alone: Implications for Sub-Saharan Africa

, , , ORCID Icon, ORCID Icon, & show all
Pages 677-692 | Received 04 Jan 2023, Accepted 20 Feb 2023, Published online: 09 Mar 2023

References

  • Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi:10.1056/NEJMoa012512
  • Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474–480. doi:10.1016/s2213-8587(14)70057-9
  • Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548):1673–1679. doi:10.1016/s0140-6736(06)69701-8
  • Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297. doi:10.1007/s00125-005-0097-z
  • Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: a Position Statement From the American College of Lifestyle Medicine. Am J Lifestyle Med. 2020;14(4):406–419. doi:10.1177/1559827620930962
  • Rosenfeld RM, Kelly JH, Agarwal M, et al. Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission: an Expert Consensus Statement from the American College of Lifestyle Medicine. Am J Lifestyle Med. 2022;16(3):342–362. doi:10.1177/15598276221087624
  • MacKay D, Chan C, Dasgupta K. Remission of Type 2 Diabetes. Can J Diabetes. 2022;46(8):753–761. doi:10.1016/j.jcjd.2022.10.004
  • Aguirre F, Brown A. IDF Diabetes Atlas. 10th. IDF; 2021.
  • McTigue KM, Wellman R, Nauman E, et al. Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: the National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020;155(5):e200087. doi:10.1001/jamasurg.2020.0087
  • Retnakaran R, Ye C, Emery A, Kramer CK, Zinman B. The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial. Nat Commun. 2022;13(1):6109. doi:10.1038/s41467-022-33867-9
  • Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. 2015;27(2):65–70. doi:10.4314/mmj.v27i2.7
  • Quaye EA, Amporful EO, Akweongo P, Aikins MK. Analysis of the Financial Cost of Diabetes Mellitus in Four Cocoa Clinics of Ghana. Value Health Reg Issues. 2015;7:49–53. doi:10.1016/j.vhri.2015.08.005
  • Mapa-Tassou C, Katte JC, Mba Maadjhou C, Mbanya JC. Economic Impact of Diabetes in Africa. Curr Diab Rep. 2019;19(2):5. doi:10.1007/s11892-019-1124-7
  • Mutyambizi C, Pavlova M, Chola L, Hongoro C, Groot W. Cost of diabetes mellitus in Africa: a systematic review of existing literature. Global Health. 2018;14(1):3. doi:10.1186/s12992-017-0318-5
  • Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2017;12(11):e0187967. doi:10.1371/journal.pone.0187967
  • Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. doi:10.1186/s12874-018-0611-x
  • Zhang Y, Yang Y, Huang Q, Zhang Q, Li M, Wu Y. The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Worldviews Evid Based Nursing. 2013;1:548. doi:10.1111/wvn.12608
  • Afulani PA, Torres JM, Sudhinaraset M, Asunka J. Transnational ties and the health of sub-Saharan African migrants: the moderating role of gender and family separation. Soc Sci Med. 2016;168:63–71. doi:10.1016/j.socscimed.2016.09.009
  • Dambha-Miller H, Day AJ, Strelitz J, Irving G, Griffin SJ. Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study. Diabet Med. 2020;37(4):681–688. doi:10.1111/dme.14122
  • Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 1991;34(12):891–898. doi:10.1007/BF00400196
  • Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care. 2014;37(7):1824–1830. doi:10.2337/dc13-2899
  • Harayama TYT, Yoshioka K, Kogure A, et al. Correlation between weight loss and improvement of diabetes mellitus among obese type 2 diabetic patients. Diabetol Int. 2013;4:132–137. doi:10.1007/s13340-013-0107-1
  • O’Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33(6):596–603. doi:10.2337/diab.33.6.596
  • Roncero-Ramos I, Gutierrez-Mariscal FM, Gomez-Delgado F, et al. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial. Transl Res. 2021;238:12–24. doi:10.1016/j.trsl.2021.07.001
  • Bhatt AA, Choudhari PK, Mahajan RR, et al. Effect of a Low-Calorie Diet on Restoration of Normoglycemia in Obese subjects with Type 2 Diabetes. Indian J Endocrinol Metab. 2017;21(5):776–780. doi:10.4103/ijem.IJEM_206_17
  • Bynoe K, Unwin N, Taylor C, et al. Inducing remission of Type 2 diabetes in the Caribbean: findings from a mixed methods feasibility study of a low-calorie liquid diet-based intervention in Barbados. Diabet Med. 2020;37(11):1816–1824. doi:10.1111/dme.14096
  • Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes. 1986;35(2):155–164. doi:10.2337/diab.35.2.155
  • Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–2514. doi:10.1007/s00125-011-2204-7
  • Quimby KR, Sobers N, George C, Greaves N, Browman-Jones F, Samuels TA. Implementation of a community-based low-calorie dietary intervention for the induction of type-2 diabetes and pre-diabetes remission: a feasibility study utilising a type 2 hybrid design. Implement Sci Commun. 2021;2(1):95. doi:10.1186/s43058-021-00196-9
  • Romano L, Marchetti M, Gualtieri P, et al. Effects of a Personalized VLCKD on Body Composition and Resting Energy Expenditure in the Reversal of Diabetes to Prevent Complications. Nutrients. 2019;11(7):1526. doi:10.3390/nu11071526
  • Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016;39(5):808–815. doi:10.2337/dc15-1942
  • Taheri S, Zaghloul H, Chagoury O, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):477–489. doi:10.1016/s2213-8587(20)30117-0
  • Thom G, Messow CM, Leslie WS, et al. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med. 2021;38(8):e14395. doi:10.1111/dme.14395
  • Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–2135. doi:10.2337/dc09-9036
  • Riddle MC, Cefalu WT, Evans PH, et al. Consensus Report: definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care. 2021;44(10):2438–2444. doi:10.2337/dci21-0034
  • National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28(12):1039–1057. doi:10.2337/diab.28.12.1039
  • ADA. Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care. 2010;33:S3. doi:10.2337/dc10-S003
  • Ades PA, Savage PD, Marney AM, Harvey J, Evans KA. Remission of recently diagnosed type 2 diabetes mellitus with weight loss and exercise. J Cardiopulm Rehabil Prev. 2015;35(3):193–197. doi:10.1097/hcr.0000000000000106
  • Brosnahan N, Leslie W, McCombie L, et al. Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). J Hum Nutr Diet. 2021;34(3):472–479. doi:10.1111/jhn.12839
  • Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7(9):726–736. doi:10.1016/S2213-8587(19)30076-2
  • Dagenais GR, Gerstein HC, Zhang X, et al. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: results from the Prospective Urban and Rural Epidemiology Study. Diabetes Care. 2016;39:780–787. doi:10.2337/dc15-2338
  • Adeyemo AA, Zaghloul NA, Chen G, et al. ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response. Nat Commun. 2019;10(1):3195. doi:10.1038/s41467-019-10967-7
  • de Rooij SR, Roseboom TJ, Painter RC. Famines in the last 100 years: implications for diabetes. Curr Diab Rep. 2014;14(10):536. doi:10.1007/s11892-014-0536-7
  • Pembrey M, Saffery R, Bygren LO. Human transgenerational responses to early-life experience: potential impact on development, health and biomedical research. J Med Genet. 2014;51(9):563–572. doi:10.1136/jmedgenet-2014-102577
  • Utumatwishima JN, Chung ST, Bentley AR, Udahogora M, Sumner AE. Reversing the tide - diagnosis and prevention of T2DM in populations of African descent. Nat Rev Endocrinol. 2018;14(1):45–56. doi:10.1038/nrendo.2017.127
  • Obesity rising in Africa. WHO analysis finds; 2022. Available from: https://www.afro.who.int/news/obesity-rising-africa-who-analysis-finds. Accessed January 29, 2023.
  • Ishimwe MCS, Wentzel A, Shoup EM, et al. Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study. BMJ Open Diabetes Res Care. 2021;9(1):e002447. doi:10.1136/bmjdrc-2021-002447
  • Ladwa M, Bello O, Hakim O, et al. Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men. BMJ Open Diabetes Res Care. 2021;9(1):e002034. doi:10.1136/bmjdrc-2020-002034